Cibc World Markets Corp Savara Inc Transaction History
Cibc World Markets Corp
- $16.6 Billion
- Q4 2024
A detailed history of Cibc World Markets Corp transactions in Savara Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 10,798 shares of SVRA stock, worth $29,694. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,798Holding current value
$29,694% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SVRA
# of Institutions
133Shares Held
149MCall Options Held
67.6KPut Options Held
29.4K-
Nea Management Company, LLC Timonium, MD24.5MShares$67.3 Million7.93% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$40.1 Million11.08% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$34 Million6.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.31MShares$22.9 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$22.4 Million1.86% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $314M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.